Squarepoint Ops LLC boosted its holdings in Chemed Corporation (NYSE:CHE – Free Report) by 50.5% during the 2nd quarter, Holdings Channel reports. The firm owned 5,201 shares of the company’s stock after acquiring an additional 1,745 shares during the period. Squarepoint Ops LLC’s holdings in Chemed were worth $2,422,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of CHE. California State Teachers Retirement System lifted its holdings in Chemed by 45,134.8% during the second quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company’s stock valued at $3,546,106,000 after purchasing an additional 7,597,086 shares during the last quarter. BlackRock Inc. purchased a new position in shares of Chemed in the second quarter worth about $691,290,000. Norges Bank purchased a new position in shares of Chemed in the fourth quarter worth about $76,067,000. Bank of America Corp DE bought a new stake in shares of Chemed in the second quarter valued at approximately $48,255,000. Finally, Caisse de depot et placement du Quebec bought a new stake in shares of Chemed in the second quarter valued at approximately $44,309,000. Institutional investors own 95.85% of the company’s stock.
Insider Buying and Selling at Chemed
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares of the company’s stock, valued at approximately $38,107,404.88. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the transaction, the director owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 5,190 shares of company stock valued at $2,803,460 in the last 90 days. Corporate insiders own 3.33% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Analysis on CHE
Chemed Stock Down 0.3%
CHE opened at $514.33 on Tuesday. The firm has a market capitalization of $6.72 billion, a P/E ratio of 25.83, a price-to-earnings-growth ratio of 1.95 and a beta of 0.51. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The company has a fifty day moving average price of $521.41 and a 200-day moving average price of $453.53. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.
Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm’s revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.
Chemed Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were issued a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, August 17th. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is 14.06%.
Chemed Profile
Chemed Corporation is a diversified holding company that operates businesses in the healthcare and residential and commercial services industries. Its primary operations are conducted through VITAS Healthcare and Roto-Rooter.
VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services are delivered in patients’ homes, hospice residences, nursing facilities, hospitals and other care settings, primarily throughout the United States. Care is provided by interdisciplinary teams that may include physicians, nurses, hospice aides, social workers and chaplains.
Roto-Rooter provides plumbing and drain-cleaning services, as well as water cleanup and related services for residential and commercial customers.
Featured Stories
- Five stocks we like better than Chemed
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
